{
  "schemaVersion": 2,
  "eyebrow": "Cardiovascular and oncology emergency",
  "title": "Superior Vena Cava Syndrome",
  "summary": "Superior vena cava syndrome requires rapid recognition of airway or cerebral compromise, contrast imaging to define obstruction, and etiologic triage between malignancy, device-associated thrombosis or stenosis, and less common mediastinal disorders.",
  "seoDescription": "Clinical approach to superior vena cava syndrome: emergency triage, imaging, malignant versus device-related obstruction, and endovascular treatment decisions.",
  "clinicalQuestion": "How should physicians triage, confirm, and direct initial treatment for suspected superior vena cava syndrome?",
  "specialty": "Cardiovascular Medicine",
  "audience": "U.S. physicians and medical trainees",
  "tags": [
    "superior vena cava syndrome",
    "SVC obstruction",
    "malignant SVC syndrome",
    "central venous catheter thrombosis",
    "SVC stenting",
    "mediastinal mass"
  ],
  "keyTakeaways": [
    "Treat stridor, rapidly progressive laryngeal edema, altered mental status, or other evidence of threatened airway or cerebral venous congestion as an emergency requiring immediate airway-capable and endovascular consultation; upper-airway obstruction is an uncommon but life-threatening presentation. [1]",
    "Obtain contrast-enhanced cross-sectional imaging to identify the level and mechanism of obstruction, associated mediastinal disease, and venous collateral pathways; chest radiography alone is insufficient to define SVC obstruction. [4][6]",
    "Malignancy accounts for approximately 70% of SVC syndrome, most often non-small cell lung cancer, small cell lung cancer, or lymphoma; central venous catheters and cardiac implantable electronic-device leads are major benign causes. [4]",
    "Differentiate extrinsic malignant compression from intrinsic device-associated fibrosis or thrombosis because the definitive pathway differs: cancer-directed therapy for malignancy and venous/device-directed management for catheter- or lead-associated disease. [18][21]",
    "Endovascular SVC stenting is an effective first-line symptom-relief strategy in lung cancer-associated SVC syndrome and may be combined with oncologic therapy rather than replacing etiologic treatment. [21]"
  ],
  "sections": [
    {
      "id": "emergency-triage",
      "eyebrow": "Immediate action",
      "heading": "Identify the small group needing emergent stabilization",
      "intro": "Triage severity before pursuing tissue diagnosis or definitive oncologic planning.",
      "paragraphs": [
        "Escalate immediately when venous obstruction produces upper-airway compromise, especially stridor or progressive airway edema, because SVC syndrome can rarely become fatal through upper-airway obstruction. Arrange monitored care with clinicians capable of definitive airway management while urgent intervention is coordinated. [1]",
        "Prioritize urgent procedural assessment when symptoms are rapidly progressive or disabling from severe head, neck, or upper-extremity venous congestion. The clinical syndrome results from partial or complete obstruction of venous return from the head and neck to the right heart; the immediate objective is to establish whether decompression is required before the underlying cause can be treated. [19]",
        "Do not presume all presentations are malignant. The cause determines both prognosis and durable treatment, and benign device-related disease is increasingly important as use of intravascular devices rises. [1][4]"
      ],
      "bullets": [
        "At presentation, document airway symptoms, dyspnea, facial or neck swelling, upper-extremity edema, cough, and visible chest-wall venous dilation; these findings support the clinical syndrome but do not establish its mechanism. [3][6]",
        "Ask specifically about an indwelling central venous catheter, hemodialysis catheter, pacemaker, implantable cardioverter-defibrillator, prior mediastinal radiation, and known or suspected thoracic malignancy. [4][17][18]"
      ],
      "subsections": [],
      "table": {
        "caption": "Initial triage priorities in suspected SVC syndrome. [1][19]",
        "columns": [
          "Clinical finding",
          "Interpretation",
          "Immediate next step"
        ],
        "rows": [
          [
            "Stridor or progressive upper-airway edema",
            "Potentially life-threatening airway compromise. [1]",
            "Arrange definitive airway-capable monitoring and urgent multidisciplinary intervention. [1]"
          ],
          [
            "Rapidly escalating venous-congestion symptoms",
            "May require urgent decompression while the cause is defined. [19]",
            "Obtain urgent contrast imaging and involve endovascular specialists. [4][21]"
          ],
          [
            "Stable facial, neck, or arm swelling with collateral veins",
            "Suggests SVC obstruction but does not distinguish malignant compression from intrinsic thrombosis or stenosis. [3][4][18]",
            "Proceed with contrast cross-sectional imaging and etiologic evaluation. [4][6]"
          ]
        ]
      }
    },
    {
      "id": "confirm-and-map-obstruction",
      "eyebrow": "Diagnostic strategy",
      "heading": "Confirm obstruction and define the anatomic mechanism",
      "intro": "Imaging must answer where the obstruction is, whether it is intrinsic or extrinsic, and what may be causing it.",
      "paragraphs": [
        "Use the clinical picture plus imaging to establish SVC syndrome. Contrast-enhanced chest imaging is used to demonstrate SVC narrowing or occlusion, assess mediastinal structures, and identify collateral venous pathways; contrast venography is also a diagnostic modality for SVC obstruction. [4][6]",
        "Interpret imaging through a mechanism-based lens. A mediastinal mass or nodal disease favors extrinsic compression from cancer, whereas an intraluminal abnormality adjacent to a central venous catheter or transvenous lead favors device-associated thrombosis, stenosis, or fibrosis. [4][18]",
        "Chest radiography can contribute to initial thoracic assessment but cannot reliably characterize SVC obstruction because the vessel may be obscured by ribs and lung shadows. Do not use a nondiagnostic radiograph to defer contrast imaging when the syndrome is clinically suspected. [4]",
        "If upper-extremity venous thrombosis is part of the differential, use the suspected upper-extremity DVT imaging pathway; when vena cava thrombosis is suspected or venous ultrasonography cannot be performed, CT venography is an option. [1][13]"
      ],
      "bullets": [
        "Record whether obstruction is partial or complete and whether collateral pathways are present, because collateral anatomy documents the hemodynamic consequence of the lesion and informs endovascular planning. [4]",
        "Review device history and the side, duration, and indication of each catheter or transvenous lead before attributing a central venous lesion to malignancy. Central venous catheters, pacemakers, defibrillators, and indwelling hemodialysis catheters are recognized causes of benign SVC syndrome. [4]"
      ],
      "subsections": [],
      "table": {
        "caption": "Etiologic patterns that redirect evaluation and definitive management. [4][17][18]",
        "columns": [
          "Pattern",
          "Most informative discriminator",
          "Likely etiologies",
          "Next management pathway"
        ],
        "rows": [
          [
            "Extrinsic mediastinal compression",
            "Cross-sectional imaging showing mass effect or mediastinal adenopathy. [4][18]",
            "Non-small cell lung cancer, small cell lung cancer, lymphoma, thymoma, germ-cell neoplasm, mesothelioma, or mediastinal metastatic disease. [4]",
            "Establish the cancer diagnosis and coordinate disease-directed therapy; consider endovascular stenting for symptom relief. [21]"
          ],
          [
            "Intrinsic catheter- or lead-associated obstruction",
            "Obstruction centered on an indwelling central venous device or transvenous lead, consistent with thrombosis, fibrosis, or stenosis. [4][18]",
            "Central venous catheter-, hemodialysis catheter-, pacemaker-, or defibrillator-associated SVC syndrome. [4]",
            "Coordinate venous and device-directed management with the service responsible for the device and endovascular specialists. [1][8]"
          ],
          [
            "Non-device benign mediastinal process",
            "Imaging without a typical cancer pattern or device-associated lesion. [4]",
            "Radiation fibrosis, idiopathic mediastinal fibrosis, retrosternal thyroid, aortic aneurysm, benign tumors, mediastinal hematoma, sarcoidosis, or infection. [4]",
            "Direct evaluation toward the identified structural or inflammatory cause; plan intervention according to anatomy and expected durability. [4]"
          ]
        ]
      }
    },
    {
      "id": "etiologic-branching",
      "eyebrow": "Cause-directed workup",
      "heading": "Use etiology to determine tissue, device, and oncology priorities",
      "intro": "The major management fork is malignant extrinsic obstruction versus benign intrinsic device-related disease.",
      "paragraphs": [
        "In suspected malignancy, use cross-sectional imaging findings to direct a diagnostic pathway for the dominant thoracic lesion rather than treating SVC syndrome as a diagnosis of cancer type. Lung cancer and lymphoma are the principal malignant causes; among all SVC syndrome cases, non-small cell lung cancer accounts for about 50%, small cell lung cancer about 25%, and lymphoma about 10% in one major etiologic summary. [4]",
        "Obtain diagnostic tissue through the safest accessible route when malignancy has not been established and the patient is stable enough to permit it. Histology changes cancer-directed management materially, particularly when imaging could represent lung cancer, lymphoma, thymoma, germ-cell neoplasm, mesothelioma, or metastatic mediastinal adenopathy. [4]",
        "In a patient with a central venous catheter or transvenous cardiac lead, regard the device as a causal possibility even when cancer is also present. Indwelling catheters tend to produce intrinsic fibrosis and thrombosis, whereas cancer more commonly produces extrinsic compression; this distinction should be explicitly resolved on imaging before choosing durable therapy. [18]",
        "Benign SVC syndrome often affects younger patients with longer anticipated survival than malignant SVC syndrome. That prognosis increases the importance of a durable venous and device strategy rather than a purely palliative approach. [4]"
      ],
      "bullets": [
        "Malignant differential: non-small cell lung cancer, small cell lung cancer, lymphoma, thymoma, primary mediastinal germ-cell neoplasm, mesothelioma, and mediastinal nodal metastases from solid tumors such as breast cancer. [4]",
        "Benign differential: central venous catheter or dialysis catheter complications, pacemaker or defibrillator leads, radiation fibrosis, idiopathic mediastinal fibrosis, sarcoidosis, retrosternal thyroid, aortic aneurysm, mediastinal hematoma, and historical infectious causes including tuberculosis and syphilis. [4]",
        "Do not overlook rare cardiac or mediastinal tumors when imaging does not show a typical pulmonary primary; primary cardiac lymphoma has presented with SVC syndrome. [5]"
      ],
      "subsections": [],
      "table": {
        "caption": "Relative etiologic distribution reported for contemporary SVC syndrome. [4]",
        "columns": [
          "Etiologic group",
          "Approximate contribution",
          "High-yield examples"
        ],
        "rows": [
          [
            "Malignancy",
            "Approximately 70% of cases. [4]",
            "Non-small cell lung cancer, small cell lung cancer, lymphoma, and other mediastinal cancers. [4]"
          ],
          [
            "Device-related benign obstruction",
            "Approximately 25% to 30% of cases. [4]",
            "Central venous catheters, pacemakers, defibrillators, and indwelling hemodialysis catheters. [4]"
          ],
          [
            "Other benign causes",
            "Approximately 1% to 5% of cases. [4]",
            "Mediastinal fibrosis, radiation fibrosis, retrosternal thyroid, aortic aneurysm, benign tumors, hematoma, sarcoidosis, and infection. [4]"
          ]
        ]
      }
    },
    {
      "id": "definitive-management",
      "eyebrow": "Intervention",
      "heading": "Relieve obstruction while treating the cause",
      "intro": "Choose a decompressive procedure and disease-directed therapy as complementary, not competing, interventions.",
      "paragraphs": [
        "Refer patients with clinically significant symptomatic obstruction for endovascular evaluation. SVC stenting is reported as an effective first-line treatment for lung cancer-associated SVC syndrome and can be combined with other cancer treatment. [21]",
        "Use stenting primarily to restore venous drainage and relieve the hemodynamic consequences of obstruction; it does not establish cancer histology or replace therapy directed at the responsible malignancy. Coordinate stent timing with the need for diagnostic tissue and the urgency of symptom control. [21]",
        "For device-associated SVC syndrome, the management problem is intrinsic venous fibrosis, stenosis, or thrombosis in the setting of a catheter or lead. Involve the appropriate device, vascular, and endovascular teams early because device removal or extraction decisions must account for ongoing pacing, defibrillation, dialysis, or infusion requirements. [4][8][18]",
        "For non-device benign structural causes, tailor definitive treatment to the anatomic lesion identified on imaging. Mediastinal fibrosis, retrosternal thyroid, aneurysm, benign tumor, and mediastinal hematoma are not interchangeable causes and should not be managed with a generic malignant-SVC pathway. [4]"
      ],
      "bullets": [
        "Malignant obstruction: establish histology when feasible, obtain oncology input for tumor-directed therapy, and use endovascular stenting when rapid symptomatic decompression is needed. [4][21]",
        "Catheter- or lead-associated obstruction: define the extent of obstruction and device dependence before selecting venous intervention or device-directed treatment. [4][8][18]",
        "All etiologies: reassess airway symptoms, dyspnea, facial and upper-extremity swelling, and collateral venous prominence after intervention to determine clinical response. [1][3]"
      ],
      "subsections": [],
      "table": {
        "caption": "Definitive management is driven by mechanism rather than symptom pattern alone. [4][18][21]",
        "columns": [
          "Mechanism",
          "Primary therapeutic objective",
          "Key coordination need"
        ],
        "rows": [
          [
            "Malignant extrinsic compression",
            "Rapid venous decompression when clinically necessary plus tumor-directed treatment. [21]",
            "Endovascular intervention and oncology, with tissue diagnosis when not already established. [4][21]"
          ],
          [
            "Device-associated intrinsic stenosis or thrombosis",
            "Restore venous patency while preserving or deliberately revising essential device access. [4][8]",
            "Electrophysiology, vascular access, nephrology, or infusion teams according to device type. [4][8]"
          ],
          [
            "Other benign mediastinal obstruction",
            "Treat the identified structural or inflammatory cause and address venous obstruction according to anatomy. [4]",
            "Condition-specific specialty involvement based on imaging findings. [4]"
          ]
        ]
      }
    },
    {
      "id": "monitoring-and-reassessment",
      "eyebrow": "Follow-up",
      "heading": "Monitor for recurrent congestion and missed alternate pathology",
      "intro": "Follow symptoms and anatomy because relief of edema alone does not establish durable resolution.",
      "paragraphs": [
        "After decompression or initiation of cause-directed treatment, reassess for recurrence or progression of dyspnea, cough, neck and facial edema, upper-extremity swelling, and chest-wall venous dilation. Recurrent symptoms should prompt repeat anatomic assessment for persistent or recurrent obstruction and reassessment of the causal process. [3][4]",
        "In malignant disease, continue management according to the confirmed cancer type and treatment plan because stenting addresses venous obstruction but not the malignant process. In benign device-related disease, reassess ongoing device necessity and venous access strategy because patients often have longer life expectancy and may require durable solutions. [4][21]",
        "Consider complications beyond edema when symptoms evolve. Chylothorax has been reported as a rare but clinically significant complication of SVC syndrome, attributable to elevated venous pressure from SVC obstruction. [24]"
      ],
      "bullets": [
        "New airway symptoms after initial evaluation require renewed urgent assessment because upper-airway obstruction is the life-threatening complication emphasized in SVC syndrome. [1]",
        "Persistent or recurrent symptoms after an intervention should not be assumed to reflect cancer progression alone; reassess stent or venous patency, device-related obstruction, and the mediastinal process on imaging. [4][18][21]"
      ],
      "subsections": [],
      "table": {
        "caption": "Post-treatment reassessment targets. [1][3][4][24]",
        "columns": [
          "Target",
          "Concerning change",
          "Action"
        ],
        "rows": [
          [
            "Airway",
            "New stridor or progressive upper-airway symptoms. [1]",
            "Urgent airway-capable reassessment and escalation. [1]"
          ],
          [
            "Venous-congestion symptoms",
            "Recurrent facial, neck, arm swelling or chest-wall collateral veins. [3]",
            "Repeat anatomic evaluation for persistent or recurrent obstruction. [4]"
          ],
          [
            "Thoracic complications",
            "Pleural fluid or respiratory deterioration compatible with chylothorax. [24]",
            "Evaluate the pleural process and reassess the hemodynamic consequence of SVC obstruction. [24]"
          ]
        ]
      }
    }
  ],
  "faq": [],
  "references": [
    {
      "number": 1,
      "title": "Superior vena cava syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice",
      "detail": "bestpractice.bmj.com",
      "url": "https://bestpractice.bmj.com/topics/en-us/848",
      "authors": "bestpractice.bmj.com",
      "host": "bestpractice.bmj.com"
    },
    {
      "number": 2,
      "title": "Endovascular therapy for superior vena cava syndrome",
      "detail": "www.thelancet.com",
      "url": "https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00250-9/fulltext",
      "authors": "www.thelancet.com",
      "host": "www.thelancet.com"
    },
    {
      "number": 3,
      "title": "Sore throat turned to be a bronchogenic carcinoma with ...",
      "detail": "casereports.bmj.com",
      "url": "https://casereports.bmj.com/content/12/12/e231738",
      "authors": "casereports.bmj.com",
      "host": "casereports.bmj.com"
    },
    {
      "number": 4,
      "title": "Superior Vena Cava Syndrome",
      "detail": "www.jacc.org",
      "url": "https://www.jacc.org/doi/10.1016/j.jcin.2020.08.038",
      "authors": "www.jacc.org",
      "host": "www.jacc.org"
    },
    {
      "number": 5,
      "title": "A Rare Case of Primary Cardiac Lymphoma Presented as Superior Vena Cava Syndrome | JACC",
      "detail": "www.jacc.org",
      "url": "https://www.jacc.org/doi/full/10.1016/j.jacc.2009.03.057",
      "authors": "www.jacc.org",
      "host": "www.jacc.org"
    },
    {
      "number": 6,
      "title": "3 Cases of Superior Vena Cava Syndrome Following ...",
      "detail": "www.jacc.org",
      "url": "https://www.jacc.org/doi/10.1016/j.jaccas.2021.09.005",
      "authors": "www.jacc.org",
      "host": "www.jacc.org"
    },
    {
      "number": 7,
      "title": "Impact of Fetal Diagnosis on the Management of Right ...",
      "detail": "www.jacc.org",
      "url": "https://www.jacc.org/doi/10.1016/j.jaccas.2025.105086",
      "authors": "www.jacc.org",
      "host": "www.jacc.org"
    },
    {
      "number": 8,
      "title": "ICD Leads Extraction and Clearing of Access Way in a Patient ...",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/md-journal/fulltext/2015/09040/icd_leads_extraction_and_clearing_of_access_way_in.9.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 9,
      "title": "Superior vena cava syndrome secondary to invasive ...",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/aort/_layouts/15/oaks.journals/downloadpdf.aspx?an=",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 10,
      "title": "Superior vena cava syndrome as a clinical... : Lung India",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/lungindia/fulltext/2016/33020/superior_vena_cava_syndrome_as_a_clinical.31.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 11,
      "title": "2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert ...",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/europace/article/20/1/e1/4158475",
      "authors": "academic.oup.com",
      "host": "academic.oup.com"
    },
    {
      "number": 12,
      "title": "26 Urgent Syndromes at the End of Life - Oxford Academic",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/book/31742/chapter/265613879",
      "authors": "academic.oup.com",
      "host": "academic.oup.com"
    },
    {
      "number": 13,
      "title": "Recommendations from the ICM-VTE: General",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/jbjsjournal/fulltext/2022/03161/recommendations_from_the_icm_vte__general.2.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 14,
      "title": "52nd ANMCO Congress Abstracts e-Posters",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/eurheartjsupp/article/23/Supplement_C/C49/6357815",
      "authors": "academic.oup.com",
      "host": "academic.oup.com"
    },
    {
      "number": 15,
      "title": "Abstracts | European Heart Journal - Cardiovascular Imaging",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/ehjcimaging/article/17/suppl_1/i1/1748301",
      "authors": "academic.oup.com",
      "host": "academic.oup.com"
    },
    {
      "number": 16,
      "title": "Thrombogenic Catheter‐Associated Superior Vena Cava ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/10.1155/2013/793054",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com"
    },
    {
      "number": 17,
      "title": "Catheter‐related superior vena cava syndrome: an ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.5694/mja2.52233",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com"
    },
    {
      "number": 18,
      "title": "Is stenting for superior vena cava syndrome ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1002/ccd.23071",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com"
    },
    {
      "number": 19,
      "title": "Oncologic emergencies and urgencies: A comprehensive review",
      "detail": "acsjournals.onlinelibrary.wiley.com",
      "url": "https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21727",
      "authors": "acsjournals.onlinelibrary.wiley.com",
      "host": "acsjournals.onlinelibrary.wiley.com"
    },
    {
      "number": 20,
      "title": "Iatrogenic Superior Vena Cava Syndrome",
      "detail": "acsjournals.onlinelibrary.wiley.com",
      "url": "https://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819840715%2954%3A2%3C376%3A%3AAID-CNCR2820540235%3E3.0.CO%3B2-R",
      "authors": "acsjournals.onlinelibrary.wiley.com",
      "host": "acsjournals.onlinelibrary.wiley.com"
    },
    {
      "number": 21,
      "title": "A retrospective stenting study on superior vena cava ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/10.1111/1759-7714.13461",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com"
    },
    {
      "number": 22,
      "title": "Clinical and Organizational Factors in the Initial Evaluation of ...",
      "detail": "journal.chestnet.org",
      "url": "https://journal.chestnet.org/article/S0012-3692(13)60292-5/fulltext",
      "authors": "journal.chestnet.org",
      "host": "journal.chestnet.org"
    },
    {
      "number": 23,
      "title": "Palliative Care in Lung Cancer - CHEST Journal",
      "detail": "journal.chestnet.org",
      "url": "https://journal.chestnet.org/article/S0012-3692(15)35532-X/abstract",
      "authors": "journal.chestnet.org",
      "host": "journal.chestnet.org"
    },
    {
      "number": 24,
      "title": "CHYLOTHORAX IN SUPERIOR VENA CAVA SYNDROME",
      "detail": "journal.chestnet.org",
      "url": "https://journal.chestnet.org/article/S0012-3692(25)03214-3/fulltext",
      "authors": "journal.chestnet.org",
      "host": "journal.chestnet.org"
    }
  ],
  "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.",
  "citations": [
    {
      "number": 1,
      "title": "Superior vena cava syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice",
      "detail": "bestpractice.bmj.com",
      "url": "https://bestpractice.bmj.com/topics/en-us/848",
      "authors": "bestpractice.bmj.com",
      "host": "bestpractice.bmj.com",
      "snippet": "###### Disclosures\n\nPeer reviewer affiliations and disclosures pertain to the time of the review.\n\n### References\n\n#### Key articles\n\nAzizi AH, Shafi I, Shah N, et al. Superior vena cava syndrome. JACC Cardiovasc Interv. 2020 Dec 28;13(24):2896-2910.Full textAbstract\n\nAmerican College of Radiology. ",
      "score": 0.7163977
    },
    {
      "number": 2,
      "title": "Endovascular therapy for superior vena cava syndrome",
      "detail": "www.thelancet.com",
      "url": "https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00250-9/fulltext",
      "authors": "www.thelancet.com",
      "host": "www.thelancet.com",
      "snippet": "by AH Azizi · 2021 · Cited by 51 — Superior vena cava (SVC) syndrome is caused by the obstruction of the SVC and can result in significant morbidity and mortality.",
      "score": 0.25075263
    },
    {
      "number": 3,
      "title": "Sore throat turned to be a bronchogenic carcinoma with ...",
      "detail": "casereports.bmj.com",
      "url": "https://casereports.bmj.com/content/12/12/e231738",
      "authors": "casereports.bmj.com",
      "host": "casereports.bmj.com",
      "snippet": "by A Elmoheen · 2019 — Symptoms commonly associated with vena cava syndrome include cough, dyspnoea, swelling of the neck, face and the upper extremities and dilation of the chest",
      "score": 0.14622158
    },
    {
      "number": 4,
      "title": "Superior Vena Cava Syndrome",
      "detail": "www.jacc.org",
      "url": "https://www.jacc.org/doi/10.1016/j.jcin.2020.08.038",
      "authors": "www.jacc.org",
      "host": "www.jacc.org",
      "snippet": "## Etiology of SVC Syndrome\n\nHistorically, prior to the development of antibiotics, SVC syndrome was predominantly attributed to syphilitic aortic aneurysms and mediastinal adenopathy from tuberculosis (8). Currently, malignancy accounts for approximately 70% of cases, with benign causes including d",
      "score": 0.65940565
    },
    {
      "number": 5,
      "title": "A Rare Case of Primary Cardiac Lymphoma Presented as Superior Vena Cava Syndrome | JACC",
      "detail": "www.jacc.org",
      "url": "https://www.jacc.org/doi/full/10.1016/j.jacc.2009.03.057",
      "authors": "www.jacc.org",
      "host": "www.jacc.org",
      "snippet": "##### Heart House\n\n##### About the Journals\n\nThe Journal of the American College of Cardiology (JACC) stands\nas a leading global resource for impactful cardiovascular research,\ndelivering essential peer-reviewed articles and crucial clinical\npractice guidelines. Gain access to authoritative medical ",
      "score": 0.4622066
    },
    {
      "number": 6,
      "title": "3 Cases of Superior Vena Cava Syndrome Following ...",
      "detail": "www.jacc.org",
      "url": "https://www.jacc.org/doi/10.1016/j.jaccas.2021.09.005",
      "authors": "www.jacc.org",
      "host": "www.jacc.org",
      "snippet": "The diagnosis of SVC syndrome is accomplished using clinical picture and supplementary imaging modalities like chest radiography, contrast",
      "score": 0.36168364
    },
    {
      "number": 7,
      "title": "Impact of Fetal Diagnosis on the Management of Right ...",
      "detail": "www.jacc.org",
      "url": "https://www.jacc.org/doi/10.1016/j.jaccas.2025.105086",
      "authors": "www.jacc.org",
      "host": "www.jacc.org",
      "snippet": "by V Suresh Kumar · 2025 — The superior vena cava (SVC) develops from fusion of venous plexuses, beginning as bilateral SVCs. There are no current guidelines on prenatal",
      "score": 0.3431661
    },
    {
      "number": 8,
      "title": "ICD Leads Extraction and Clearing of Access Way in a Patient ...",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/md-journal/fulltext/2015/09040/icd_leads_extraction_and_clearing_of_access_way_in.9.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "In the meantime, the superior vena cava syndrome associated with internal leads may be a benign condition, or a debilitating and sometimes intractable",
      "score": 0.42993253
    },
    {
      "number": 9,
      "title": "Superior vena cava syndrome secondary to invasive ...",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/aort/_layouts/15/oaks.journals/downloadpdf.aspx?an=",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "The diagnostic evaluation of Superior Vena Cava (SVC) syndrome begins with a detailed clinical assessment and grading of the condition based on symptom",
      "score": 0.5417246
    },
    {
      "number": 10,
      "title": "Superior vena cava syndrome as a clinical... : Lung India",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/lungindia/fulltext/2016/33020/superior_vena_cava_syndrome_as_a_clinical.31.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "by K Jumean · 2016 · Cited by 4 — Superior vena cava (SVC) syndrome occurs when the SVC is obstructed by either external compression or thrombosis.[ 1 ] Majority of the causes are secondary to",
      "score": 0.34561363
    },
    {
      "number": 11,
      "title": "2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert ...",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/europace/article/20/1/e1/4158475",
      "authors": "academic.oup.com",
      "host": "academic.oup.com",
      "snippet": "by H Calkins · 2018 · Cited by 5004 — superior vena cava TEE. The RSPV lies just behind the superior vena cava (SVC) or RA, This figure includes six CT or MR images of the left.",
      "score": 0.23204939
    },
    {
      "number": 12,
      "title": "26 Urgent Syndromes at the End of Life - Oxford Academic",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/book/31742/chapter/265613879",
      "authors": "academic.oup.com",
      "host": "academic.oup.com",
      "snippet": "The primary causes of superior vena cava obstruction (SVCO) are lung cancer, lymphomas, thrombus, and stenosis secondary to venous lines.",
      "score": 0.21479884
    },
    {
      "number": 13,
      "title": "Recommendations from the ICM-VTE: General",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/jbjsjournal/fulltext/2022/03161/recommendations_from_the_icm_vte__general.2.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "In patients with suspicion of iliac or vena cava thrombosis, or impossible to perform VUS, computer tomography venography (CTV) . Strength of",
      "score": 0.17092308
    },
    {
      "number": 14,
      "title": "52nd ANMCO Congress Abstracts e-Posters",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/eurheartjsupp/article/23/Supplement_C/C49/6357815",
      "authors": "academic.oup.com",
      "host": "academic.oup.com",
      "snippet": "... superior vena cava (SVC) with average values ​​equal to 21 mmHg. A transesophageal echocardiogram (TEE) ruled out the possibility of",
      "score": 0.12280721
    },
    {
      "number": 15,
      "title": "Abstracts | European Heart Journal - Cardiovascular Imaging",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/ehjcimaging/article/17/suppl_1/i1/1748301",
      "authors": "academic.oup.com",
      "host": "academic.oup.com",
      "snippet": "We determined collateral flow by using the commonly used equation: flow volume aorta ascendens–(flow volume superior vena cava + flow volume inferior vena cava).",
      "score": 0.105311915
    },
    {
      "number": 16,
      "title": "Thrombogenic Catheter‐Associated Superior Vena Cava ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/10.1155/2013/793054",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com",
      "snippet": "SVC syndrome is associated with malignancies like nonsmall-cell lung cancer, Other causes include mediastinal fibrosis, vascular diseases,",
      "score": 0.68723184
    },
    {
      "number": 17,
      "title": "Catheter‐related superior vena cava syndrome: an ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.5694/mja2.52233",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com",
      "snippet": "by JJ Harvey · 2024 · Cited by 2 — About 60% of SVCS cases are caused by intrathoracic malignancy, typically primary lung cancer or lymphoma, but non-malignant causes are",
      "score": 0.55449516
    },
    {
      "number": 18,
      "title": "Is stenting for superior vena cava syndrome ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1002/ccd.23071",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com",
      "snippet": "by B Gray · 2011 · Cited by 6 — To the practicing clinician, cancer leads to extrinsic compression, whereas indwelling catheters lead to intrinsic fibrosis and thrombosis.",
      "score": 0.5191075
    },
    {
      "number": 19,
      "title": "Oncologic emergencies and urgencies: A comprehensive review",
      "detail": "acsjournals.onlinelibrary.wiley.com",
      "url": "https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21727",
      "authors": "acsjournals.onlinelibrary.wiley.com",
      "host": "acsjournals.onlinelibrary.wiley.com",
      "snippet": "Superior vena cava syndrome results from partial or complete obstruction of blood return from the head and neck to the right heart",
      "score": 0.45784017
    },
    {
      "number": 20,
      "title": "Iatrogenic Superior Vena Cava Syndrome",
      "detail": "acsjournals.onlinelibrary.wiley.com",
      "url": "https://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819840715%2954%3A2%3C376%3A%3AAID-CNCR2820540235%3E3.0.CO%3B2-R",
      "authors": "acsjournals.onlinelibrary.wiley.com",
      "host": "acsjournals.onlinelibrary.wiley.com",
      "snippet": "by M Bertrand · 1984 · Cited by 103 — Four patients with cancer developed superior vena cava syndrome following placement of a central venous catheter (Broviac or Hickman catheter)",
      "score": 0.40204045
    },
    {
      "number": 21,
      "title": "A retrospective stenting study on superior vena cava ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/10.1111/1759-7714.13461",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com",
      "snippet": "SVC stenting is effective as a first-line treatment modality for patients with SVCS caused by lung cancer. In combination with other treatment",
      "score": 0.3650723
    },
    {
      "number": 22,
      "title": "Clinical and Organizational Factors in the Initial Evaluation of ...",
      "detail": "journal.chestnet.org",
      "url": "https://journal.chestnet.org/article/S0012-3692(13)60292-5/fulltext",
      "authors": "journal.chestnet.org",
      "host": "journal.chestnet.org",
      "snippet": "by DE Ost · 2013 · Cited by 307 — Paraneoplastic syndromes may have an adverse impact on cancer treatment, thoracic surgery, medical oncology, Superior vena cava syndrome with malignant causes",
      "score": 0.48162505
    },
    {
      "number": 23,
      "title": "Palliative Care in Lung Cancer - CHEST Journal",
      "detail": "journal.chestnet.org",
      "url": "https://journal.chestnet.org/article/S0012-3692(15)35532-X/abstract",
      "authors": "journal.chestnet.org",
      "host": "journal.chestnet.org",
      "snippet": "by PA Kvale · 2007 · Cited by 322 — superior vena cava syndrome; Symptoms referable to distant extrathoracic metastases to bone, brain, spinal cord, and liver pose additional problems. Clinical",
      "score": 0.39599866
    },
    {
      "number": 24,
      "title": "CHYLOTHORAX IN SUPERIOR VENA CAVA SYNDROME",
      "detail": "journal.chestnet.org",
      "url": "https://journal.chestnet.org/article/S0012-3692(25)03214-3/fulltext",
      "authors": "journal.chestnet.org",
      "host": "journal.chestnet.org",
      "snippet": "Chylothorax is a rare but significant complication of superior vena cava (SVC) syndrome, where obstruction of the SVC leads to increased pressure in the",
      "score": 0.18203293
    }
  ],
  "publishedAt": "2026-08-24T17:19:19.541643+00:00",
  "updatedAt": "2026-08-24T17:19:19.541643+00:00",
  "readingMinutes": 6,
  "slug": "superior-vena-cava-syndrome"
}
